| Ident. | Authors (with country if any) | Title |
|---|
| 000149 (2020) |
Stacy Gelhaus Wendell ; Hao Fan ; Cheng Zhang | G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action |
| 000362 (2019) |
Evangelos Koustas ; Panagiotis Sarantis ; Georgia Kyriakopoulou ; Athanasios G. Papavassiliou ; Michalis V. Karamouzis [Grèce] | The Interplay of Autophagy and Tumor Microenvironment in Colorectal Cancer—Ways of Enhancing Immunotherapy Action |
| 000473 (2019) |
Chunfa Chen [République populaire de Chine] ; Yongle Yang [République populaire de Chine] ; Meng-Fei Yu [République populaire de Chine] ; Shunbo Shi [République populaire de Chine] ; Shuhui Han [République populaire de Chine] ; Qing-Hua Liu [République populaire de Chine] ; Congli Cai [République populaire de Chine] ; Jinhua Shen [République populaire de Chine] | Relaxant Action of Diclofenac Sodium on Mouse Airway Smooth Muscle |
| 000494 (2019) |
Marta Gozzi ; Blagoje Murganic ; Dijana Dra A ; John Popp ; Peter Coburger ; Danijela Maksimovi Vani ; Sanja Mijatovi ; Evamarie Hey-Hawkins | Quinoline‐Conjugated Ruthenacarboranes: Toward Hybrid Drugs with a Dual Mode of Action |
| 000651 (2019) |
Alejandro M. S. Mayer ; Aimee J. Guerrero ; Abimael D. Rodríguez ; Orazio Taglialatela-Scafati ; Fumiaki Nakamura ; Nobuhiro Fusetani | Marine Pharmacology in 2014–2015: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, Antiviral, and Anthelmintic Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action |
| 000938 (2019) |
Kaveh Eghbalzadeh [Allemagne] ; Leena Georgi [Allemagne] ; Theresa Louis [Allemagne] ; Haizhi Zhao [Allemagne] ; Ugur Keser [Allemagne] ; Carolyn Weber [Allemagne] ; Martin Mollenhauer [Allemagne] ; Andreas Conforti [Allemagne] ; Thorsten Wahlers [Allemagne] ; Adnana Paunel-Görgülü [Allemagne] | Compromised Anti-inflammatory Action of Neutrophil Extracellular Traps in PAD4-Deficient Mice Contributes to Aggravated Acute Inflammation After Myocardial Infarction |
| 000A75 (2019) |
Jing-Ze Yu [République populaire de Chine] ; Yi Ying [République populaire de Chine] ; Yang Liu [République populaire de Chine] ; Chun-Bin Sun [République populaire de Chine] ; Chen Dai [République populaire de Chine] ; Shan Zhao [République populaire de Chine] ; Shou-Zheng Tian [République populaire de Chine] ; Jing Peng [République populaire de Chine] ; Ni-Ping Han [République populaire de Chine] ; Jia-Li Yuan [République populaire de Chine] ; Jin-Yuan Yan [République populaire de Chine] ; Zhong-Shan Yang [République populaire de Chine] | Antifibrotic action of Yifei Sanjie formula enhanced autophagy via PI3K-AKT-mTOR signaling pathway in mouse model of pulmonary fibrosis. |
| 000A77 (2019) |
Claudia Riccardi ; Domenica Musumeci ; Marco Trifuoggi ; Carlo Irace ; Luigi Paduano ; Daniela Montesarchio | Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity |
| 000C48 (2018) |
Mija Marinkovi [Croatie] ; Matilda Šprung [Croatie] ; Maja Buljubaši [Croatie] ; Ivana Novak [Croatie] | Autophagy Modulation in Cancer: Current Knowledge on Action and Therapy. |
| 000F90 (2014-12-03) |
Maribel Navarro [Venezuela] ; William Castro [Venezuela] ; Marilyn Madamet [France] ; Rémy Amalvict [France] ; Nicolas Benoit [France] ; Bruno Pradines [France] | Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action |
| 001387 (2012) |
Richard K. Haynes [République populaire de Chine, Hong Kong, Italie] ; Kwan-Wing Cheu [République populaire de Chine] ; Ho-Wai Chan [République populaire de Chine] ; Ho-Ning Wong [République populaire de Chine] ; Ka-Yan Li [République populaire de Chine] ; Maggie Mei-Ki Tang [République populaire de Chine] ; Min-Jiao Chen [République populaire de Chine] ; Zu-Feng Guo [République populaire de Chine] ; Zhi-Hong Guo [République populaire de Chine] ; Kumar Sinniah [États-Unis] ; Amanda B. Witte [États-Unis] ; Paolo Coghi [Italie] ; Diego Monti [Italie] | Interactions between Artemisinins and other Antimalarial Drugs in Relation to the Cofactor Model—A Unifying Proposal for Drug Action |
| 001594 (2011) |
Richard K. Haynes [Hong Kong, Italie] ; Kwan-Wing Cheu ; Ka-Yan Li ; Maggie Mei-Ki Tang ; Ho-Ning Wong ; Min-Jiao Chen ; Zu-Feng Guo ; Zhi-Hong Guo ; Paolo Coghi [Italie] ; Diego Monti [Italie] | A Partial Convergence in Action of Methylene Blue and Artemisinins: Antagonism with Chloroquine, a Reversal with Verapamil, and an Insight into the Antimalarial Activity of Chloroquine |
| 001626 (2010) |
Shuyu Ren [Suisse] ; Cuiyan Xin ; Josef Pfeilschifter ; Andrea Huwiler | A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation. |
| 001860 (2009) |
Paolo Coghi ; Nicoletta Basilico [Italie] ; Donatella Taramelli [Italie] ; Wing-Chi Chan ; Richard Haynes [Hong Kong] ; Diego Monti [Italie] | Interaction of Artemisinins with Oxyhemoglobin Hb–FeII, Hb–FeII, CarboxyHb–FeII, Heme–FeII, and Carboxyheme FeII: Significance for Mode of Action and Implications for Therapy of Cerebral Malaria |
| 001B27 (2007) |
Sunil Kalia ; Jan P. Dutz | New concepts in antimalarial use and mode of action in dermatology |
| 001E05 (2005) |
Christophe Biot [France] ; Donatella Taramelli [Italie] ; Lucien Maciejewski [France] ; Mlandzeni Boyce [Afrique du Sud] ; Guy Nowogrocki [France] ; Jacques Brocard [France] ; Nicoletta Basilico [Italie] ; Piero Olliaro [Suisse] ; Timothy Egan [Afrique du Sud] | Insights into the Mechanism of Action of Ferroquine. Relationship between Physicochemical Properties and Antiplasmodial Activity |
| 002547 (2000) |
Chantal Etiévant ; Anna Kruczynski ; Jean-Marc Barret ; Dominique Perrin ; Benoît Van Hille ; Yves Guminski ; Bridget T. Hill | F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103 |
| 002838 (1998) |
Jan Bondeson [Suède] ; Roger Sundler [Suède] | Antimalarial Drugs Inhibit Phospholipase A2 Activation and Induction of Interleukin lβ and Tumor Necrosis Factor α in Macrophages: Implications for Their Mode of Action in Rheumatoid Arthritis |
| 002B58 (1995) |
Toshiro Takatori [Japon] ; Takeshi Koizumi [Japon] ; Taro Tokui [Japon] ; Yoshihiro Mitsuhashi [Japon] ; Akio Shiraishi [Japon] ; Takashi Tsuruo [Japon] | Intracellular activation and cytotoxic action of RS-1541 against cultured human tumor cells |
| 002D02 (1994) |
E. Pussard [France] ; F. Verdier [France] | Antimalarial 4‐aminoquinolines: mode of action and pharmacokinetics |
| 003247 (1988) |
Cyril X. George [États-Unis] ; Charles E. Samuel [États-Unis] | Mechanism of interferon action Expression of reovirus S6 gene in transfected COS cells and subsequent inhibition at the level of protein synthesis by type I but not by type ii interferon |
